Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Viruses
|
March 26, 2022
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern
Lixiao Xing, Xinfeng Xu, Wei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 10, 2023
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates
Zezhong Liu, Jie Zhou, Xinling Wang, et al.
Advanced Healthcare Materials
|
November 14, 2023
Intranasal G5-BGG/pDNA Vaccine Elicits Protective Systemic and Mucosal Immunity against SARS-CoV-2 by Transfecting Mucosal Dendritic Cells
Han Zhang, Zezhong Liu, Hongye Lihe, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 16, 2026
Rational Design of Broad-Spectrum Anti-Enteroviral Molecular Glues Targeting Enteroviral RNAi Suppressors
Yuan Fang, Xiong Xie, Huidi Fan, et al.
Acta Pharmaceutica Sinica. B
|
August 9, 2021
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
Jie Zhou, Wei Xu, Zezhong Liu, et al.
Cell Reports. Medicine
|
March 1, 2024
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Signal Transduction and Targeted Therapy
|
November 28, 2020
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Viruses
|
March 26, 2022
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
Naru Zhang, Qianting Ji, Zezhong Liu, et al.
Cell Research
|
February 25, 2022
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant
Zezhong Liu, Jasper Fuk-Woo Chan, Jie Zhou, et al.
Medcomm
|
July 8, 2025
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants
Guangxu Zhang, Qian Wang, Kai Ji, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Viruses
|
March 26, 2022
A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern
Lixiao Xing, Xinfeng Xu, Wei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 10, 2023
A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates
Zezhong Liu, Jie Zhou, Xinling Wang, et al.
Advanced Healthcare Materials
|
November 14, 2023
Intranasal G5-BGG/pDNA Vaccine Elicits Protective Systemic and Mucosal Immunity against SARS-CoV-2 by Transfecting Mucosal Dendritic Cells
Han Zhang, Zezhong Liu, Hongye Lihe, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 16, 2026
Rational Design of Broad-Spectrum Anti-Enteroviral Molecular Glues Targeting Enteroviral RNAi Suppressors
Yuan Fang, Xiong Xie, Huidi Fan, et al.
Acta Pharmaceutica Sinica. B
|
August 9, 2021
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
Jie Zhou, Wei Xu, Zezhong Liu, et al.
Cell Reports. Medicine
|
March 1, 2024
Neutralization of SARS-CoV-2 BA.2.86 and JN.1 by CF501 adjuvant-enhanced immune responses targeting the conserved epitopes in ancestral RBD
Zezhong Liu, Jie Zhou, Weijie Wang, et al.
Signal Transduction and Targeted Therapy
|
November 28, 2020
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Viruses
|
March 26, 2022
Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
Naru Zhang, Qianting Ji, Zezhong Liu, et al.
Cell Research
|
February 25, 2022
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant
Zezhong Liu, Jasper Fuk-Woo Chan, Jie Zhou, et al.
Medcomm
|
July 8, 2025
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants
Guangxu Zhang, Qian Wang, Kai Ji, et al.
Page
of 5